PedvaxHIB®

BIOLOGICAL3 trials

Sponsors

GlaxoSmithKline

Conditions

Haemophilus Influenzae Type bInfections, StreptococcalNeisseria Meningitidis

Phase 2

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

CompletedNCT00134719

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2005-04-11End: 2007-02-21Updated: 2018-07-19

Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children

CompletedNCT01545375

GlaxoSmithKlineInfections, Streptococcal

Start: 2012-05-21End: 2016-07-26Updated: 2019-12-27

Phase 3

Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age

CompletedNCT01978093

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2014-02-01End: 2016-03-18Updated: 2018-09-14

Related Papers

Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study

Vaccine2019-10-1640 citations

Immunogenicity and safety of the <i>Haemophilus influenzae</i> type b and <i>Neisseria meningitidis</i> serogroups C and Y-tetanus toxoid conjugate vaccine co-administered with human rotavirus, hepatitis A and 13-valent pneumococcal conjugate vaccines: results from a phase III, randomized, multicenter study in infants

Human Vaccines & Immunotherapeutics2018-09-254 citations

Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials.

2012-08-017 citations